vs
Certara, Inc.（CERT）与IDEAYA Biosciences, Inc.（IDYA）财务数据对比。点击上方公司名可切换其他公司
IDEAYA Biosciences, Inc.的季度营收约是Certara, Inc.的1.9倍（$207.8M vs $106.9M），IDEAYA Biosciences, Inc.净利率更高（57.4% vs -8.2%，领先65.6%）
Certara是全球领先的生物制药软件及咨询服务提供商，专注于建模模拟、监管科学领域的解决方案，服务药企、生物技术企业及医疗相关方，覆盖药物研发全周期，助力加快新疗法上市，降低研发风险与综合成本。
IDEAYA Biosciences是一家临床阶段生物技术企业，专注于肿瘤学领域，研发针对基因定义癌症的靶向疗法及合成致死治疗方案，推进多肿瘤类型的候选药物管线开发，与行业伙伴合作提升全球创新癌症治疗方案的可及性。
CERT vs IDYA — 直观对比
营收规模更大
IDYA
是对方的1.9倍
$106.9M
净利率更高
IDYA
高出65.6%
-8.2%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $106.9M | $207.8M |
| 净利润 | $-8.8M | $119.2M |
| 毛利率 | 61.1% | — |
| 营业利润率 | 34.9% | 52.2% |
| 净利率 | -8.2% | 57.4% |
| 营收同比 | 0.8% | — |
| 净利润同比 | -287.2% | 330.1% |
| 每股收益（稀释后） | $-0.06 | $1.33 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CERTIDYA
| Q1 26 | $106.9M | — | ||
| Q4 25 | $103.6M | — | ||
| Q3 25 | $104.6M | $207.8M | ||
| Q2 25 | $104.6M | — | ||
| Q1 25 | $106.0M | — | ||
| Q4 24 | $100.4M | — | ||
| Q3 24 | $94.8M | $0 | ||
| Q2 24 | $93.3M | $0 |
净利润CERTIDYA
| Q1 26 | $-8.8M | — | ||
| Q4 25 | $-5.9M | — | ||
| Q3 25 | $1.5M | $119.2M | ||
| Q2 25 | $-2.0M | — | ||
| Q1 25 | $4.7M | — | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $-1.4M | $-51.8M | ||
| Q2 24 | $-12.6M | $-52.8M |
毛利率CERTIDYA
| Q1 26 | 61.1% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
营业利润率CERTIDYA
| Q1 26 | 34.9% | — | ||
| Q4 25 | 0.8% | — | ||
| Q3 25 | 2.9% | 52.2% | ||
| Q2 25 | 9.1% | — | ||
| Q1 25 | 7.2% | — | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | -9.7% | — |
净利率CERTIDYA
| Q1 26 | -8.2% | — | ||
| Q4 25 | -5.7% | — | ||
| Q3 25 | 1.5% | 57.4% | ||
| Q2 25 | -1.9% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | -1.4% | — | ||
| Q2 24 | -13.5% | — |
每股收益（稀释后）CERTIDYA
| Q1 26 | $-0.06 | — | ||
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $0.01 | $1.33 | ||
| Q2 25 | $-0.01 | — | ||
| Q1 25 | $0.03 | — | ||
| Q4 24 | $0.04 | — | ||
| Q3 24 | $-0.01 | $-0.60 | ||
| Q2 24 | $-0.08 | $-0.68 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $149.5M | $786.9M |
| 总债务越低越好 | $3.0M | — |
| 股东权益账面价值 | $1.0B | $1.1B |
| 总资产 | $1.5B | $1.2B |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资CERTIDYA
| Q1 26 | $149.5M | — | ||
| Q4 25 | $189.4M | — | ||
| Q3 25 | $172.7M | $786.9M | ||
| Q2 25 | $162.3M | — | ||
| Q1 25 | $179.1M | — | ||
| Q4 24 | $179.2M | — | ||
| Q3 24 | $233.0M | $920.0M | ||
| Q2 24 | $224.6M | $701.7M |
总债务CERTIDYA
| Q1 26 | $3.0M | — | ||
| Q4 25 | $293.1M | — | ||
| Q3 25 | $293.5M | — | ||
| Q2 25 | $294.2M | — | ||
| Q1 25 | $294.8M | — | ||
| Q4 24 | $295.4M | — | ||
| Q3 24 | $296.1M | — | ||
| Q2 24 | $296.7M | — |
股东权益CERTIDYA
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | $1.2B | ||
| Q2 24 | $1.0B | $931.7M |
总资产CERTIDYA
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.5B | $1.2B | ||
| Q2 24 | $1.5B | $973.7M |
负债/权益比CERTIDYA
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.28× | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.28× | — | ||
| Q2 24 | 0.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.7M | $142.2M |
| 自由现金流经营现金流 - 资本支出 | — | $142.2M |
| 自由现金流率自由现金流/营收 | — | 68.4% |
| 资本支出强度资本支出/营收 | 0.6% | 0.0% |
| 现金转化率经营现金流/净利润 | — | 1.19× |
| 过去12个月自由现金流最近4个季度 | — | $13.5M |
8季度趋势，按日历期对齐
经营现金流CERTIDYA
| Q1 26 | $11.7M | — | ||
| Q4 25 | $28.8M | — | ||
| Q3 25 | $32.3M | $142.2M | ||
| Q2 25 | $17.8M | — | ||
| Q1 25 | $17.4M | — | ||
| Q4 24 | $49.4M | — | ||
| Q3 24 | $17.0M | $-49.2M | ||
| Q2 24 | $9.8M | $-32.9M |
自由现金流CERTIDYA
| Q1 26 | — | — | ||
| Q4 25 | $27.8M | — | ||
| Q3 25 | $32.1M | $142.2M | ||
| Q2 25 | $17.8M | — | ||
| Q1 25 | $16.8M | — | ||
| Q4 24 | $49.0M | — | ||
| Q3 24 | $16.8M | $-49.7M | ||
| Q2 24 | $9.4M | $-33.9M |
自由现金流率CERTIDYA
| Q1 26 | — | — | ||
| Q4 25 | 26.8% | — | ||
| Q3 25 | 30.7% | 68.4% | ||
| Q2 25 | 17.0% | — | ||
| Q1 25 | 15.8% | — | ||
| Q4 24 | 48.8% | — | ||
| Q3 24 | 17.7% | — | ||
| Q2 24 | 10.1% | — |
资本支出强度CERTIDYA
| Q1 26 | 0.6% | — | ||
| Q4 25 | 1.0% | — | ||
| Q3 25 | 0.2% | 0.0% | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.5% | — |
现金转化率CERTIDYA
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 21.19× | 1.19× | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.66× | — | ||
| Q4 24 | 7.51× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
